208 related articles for article (PubMed ID: 10920127)
1. Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.
Bennett CL; Stinson TJ; Vogel V; Robertson L; Leedy D; O'Brien P; Hobbs J; Sutton T; Ruckdeschel JC; Chirikos TN; Weiner RS; Ramsey MM; Wicha MS
J Clin Oncol; 2000 Aug; 18(15):2805-10. PubMed ID: 10920127
[TBL] [Abstract][Full Text] [Related]
2. Clinical trials: are they a good buy?
Bennett CL; Adams JR; Knox KS; Kelahan AM; Silver SM; Bailes JS
J Clin Oncol; 2001 Dec; 19(23):4330-9. PubMed ID: 11731516
[TBL] [Abstract][Full Text] [Related]
3. Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?
Bennett CL; Golub R; Waters TM; Tallman MS; Rowe JM
Cancer Invest; 1997; 15(3):227-36. PubMed ID: 9171857
[TBL] [Abstract][Full Text] [Related]
4. Measuring the incremental cost of clinical cancer research.
Goldman DP; Schoenbaum ML; Potosky AL; Weeks JC; Berry SH; Escarce JJ; Weidmer BA; Kilgore ML; Wagle N; Adams JL; Figlin RA; Lewis JH; Cohen J; Kaplan R; McCabe M
J Clin Oncol; 2001 Jan; 19(1):105-10. PubMed ID: 11134202
[TBL] [Abstract][Full Text] [Related]
5. Cost considerations in the management of cancer in the older patient.
McKoy JM; Fitzner KA; Edwards BJ; Alkhatib M; Tigue CC; Nonzee NJ; Bolden CR; Bennett CL
Oncology (Williston Park); 2007 Jun; 21(7):851-7; discussion 858, 860, 862 passim. PubMed ID: 17722744
[TBL] [Abstract][Full Text] [Related]
6. Reimbursement issues facing patients, providers, and payers.
Antman K
Cancer; 1993 Nov; 72(9 Suppl):2842-5. PubMed ID: 8402516
[TBL] [Abstract][Full Text] [Related]
7. Incremental treatment costs in national cancer institute-sponsored clinical trials.
Goldman DP; Berry SH; McCabe MS; Kilgore ML; Potosky AL; Schoenbaum ML; Schonlau M; Weeks JC; Kaplan R; Escarce JJ
JAMA; 2003 Jun; 289(22):2970-7. PubMed ID: 12799405
[TBL] [Abstract][Full Text] [Related]
8. Benefit of a favorable cardiovascular risk-factor profile in middle age with respect to Medicare costs.
Daviglus ML; Liu K; Greenland P; Dyer AR; Garside DB; Manheim L; Lowe LP; Rodin M; Lubitz J; Stamler J
N Engl J Med; 1998 Oct; 339(16):1122-9. PubMed ID: 9770560
[TBL] [Abstract][Full Text] [Related]
9. Third-party payers and the cost of biomedical research.
Iltis AS
Kennedy Inst Ethics J; 2005 Jun; 15(2):135-60. PubMed ID: 16149205
[TBL] [Abstract][Full Text] [Related]
10. Enrollment of older persons in cancer trials after the medicare reimbursement policy change.
Gross CP; Wong N; Dubin JA; Mayne ST; Krumholz HM
Arch Intern Med; 2005 Jul; 165(13):1514-20. PubMed ID: 16009867
[TBL] [Abstract][Full Text] [Related]
11. Using patients as their own controls for cost evaluation of phase I clinical trials.
Sherman EJ; Rubin DM; Venkatraman E; Schwartz GK; Miller VA; Radzyner MH; Ruchlin HS; Spriggs D; Pfister DG
J Clin Oncol; 2004 Apr; 22(7):1308-14. PubMed ID: 15051779
[TBL] [Abstract][Full Text] [Related]
12. A framework for workflow-based clinical research billing disambiguation.
Payne PR; Borlawsky T; Kamal J; Saltz JH
AMIA Annu Symp Proc; 2007 Oct; ():1071. PubMed ID: 18694169
[TBL] [Abstract][Full Text] [Related]
13. Impact of clinical trial protocols on patient care systems at the University of Texas M.D. Anderson Cancer Center.
Huber SL
Cancer; 1993 Nov; 72(9 Suppl):2824-7. PubMed ID: 8402512
[TBL] [Abstract][Full Text] [Related]
14. Measuring costs: administrative claims data, clinical trials, and beyond.
Etzioni R; Riley GF; Ramsey SD; Brown M
Med Care; 2002 Jun; 40(6 Suppl):III63-72. PubMed ID: 12064760
[TBL] [Abstract][Full Text] [Related]
15. Do older Medicare patients cost hospitals more? Evidence from an academic medical center.
Rosenthal GE; Landefeld CS
Arch Intern Med; 1993 Jan; 153(1):89-96. PubMed ID: 8422203
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a community setting: A cost-utility analysis of a hospital's initial experience and reflections on the health care system.
Naffouje SA; O'Donoghue C; Salti GI
J Surg Oncol; 2016 Apr; 113(5):544-7. PubMed ID: 26750613
[TBL] [Abstract][Full Text] [Related]
17. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
18. Integrating economic analysis into cancer clinical trials: the National Cancer Institute-American Society of Clinical Oncology Economics Workbook.
J Natl Cancer Inst Monogr; 1998; (24):1-28. PubMed ID: 9704318
[No Abstract] [Full Text] [Related]
19. Administrative and claims records as sources of health care cost data.
Riley GF
Med Care; 2009 Jul; 47(7 Suppl 1):S51-5. PubMed ID: 19536019
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
